Global Probiotics Strain Market Outlook of Size, Share, and Growth from 2024 to 2029 by Type, Application, Region, and Player

1. Global Probiotics Strain Market Outlook

The global probiotics strain market revenue is anticipated to reach $1926.18 million in 2024, with a CAGR of 8.59% from 2024 to 2029. Probiotics strains, defined as live microorganisms that confer health benefits when administered in adequate amounts, are gaining traction for their potential to support digestive health, immune function, and overall well-being. These beneficial bacteria and yeasts are increasingly being integrated into food and beverage products, dietary supplements, and pharmaceutical applications, reflecting a growing consumer demand for health-promoting products.

Global Probiotics Strain Market Revenue(M USD)  in 2024

2. Probiotics Strain Market Growth Drivers

The market for probiotic strains is driven by several key factors. Firstly, the increasing global population and the continuous growth in downstream demand are contributing to the expansion of the market. Economic development in regions like Asia Pacific, particularly in countries such as China, Japan, and India, has led to a significant increase in disposable incomes, which in turn boosts the demand for probiotic-based products. Additionally, the rising awareness of health and wellness, along with the growing trend of preventive healthcare, is fostering a preference for natural and probiotic-rich foods and supplements among consumers.

Technological advancements in the field of probiotics have also played a crucial role in market growth. Innovations in strain development and delivery systems have improved the efficacy and accessibility of probiotics, making them more appealing to consumers. Furthermore, the food and beverage industry’s expansion, especially in the Asia Pacific region, is creating new opportunities for the incorporation of probiotic strains into a variety of products, thereby driving market growth.

3. Probiotics Strain Market Limiting Factors

Despite the positive growth trajectory, the probiotics strain market faces certain challenges that could limit its expansion. One of the primary constraints is the need to meet international quality standards and regulations for probiotic products. Organizations such as the FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics have established guidelines that can lead to the substantiation of health claims related to probiotic agents, which can be a complex and costly process for manufacturers.

Another limiting factor is the complexity involved in integrating probiotic strains into functional foods. The success of such products depends on consumer demand, technological capabilities, and legislative regulatory frameworks. Consumers’ lack of knowledge about the health effects of specific ingredients can hinder the acceptance of functional foods enriched with probiotics. Moreover, the risk of contamination during the cultivation and production process poses a significant challenge, as probiotic products are highly dependent on the cultivation by living organisms, making them vulnerable to microbial contamination.

In conclusion, while the global probiotics strain market is poised for significant growth, it must navigate through a complex regulatory environment and technological challenges to fully realize its potential. Despite these hurdles, the market’s prospects remain promising, driven by a growing consumer base that values health and wellness, and a food industry that is increasingly incorporating probiotics into its product offerings.

4. Analysis of Probiotics Strain Market Segment

Product Types of Probiotics Strain

The global probiotics strain market is diversified, with various product types playing significant roles in human and animal health. The product types are primarily classified based on the strains of bacteria they contain, which are known for their health benefits.

Lactobacillus acidophilus

Lactobacillus acidophilus is a strain of bacteria that is naturally found in the human gut and is known for its ability to promote healthy gut flora and support immune health. In 2024, this product type is projected to generate a substantial market revenue of $458.25 million, reflecting its widespread use in dietary supplements and food products. Its market share is significant due to its established reputation and consumer recognition.

Lactobacillus rhamnosus GG

Lactobacillus rhamnosus GG, commonly referred to as LGG, is a specific strain of bacteria that has been extensively studied for its health benefits, particularly in enhancing gut health and potentially reducing symptoms of irritable bowel syndrome. The market revenue for LGG is expected to be $302.27 million in 2024, with a steady growth rate due to its strong scientific backing and increasing consumer demand for natural health solutions.

Bifidobacterium bifidum

Bifidobacterium bifidum is a strain of bacteria that is one of the most common probiotic bacteria found in the human gut. It is known for its role in improving gut health and boosting the immune system. In 2024, Bifidobacterium bifidum is anticipated to have a substantial market value of $873.37 million, driven by its use in a variety of food and beverage products, as well as dietary supplements.

Among these product types, Bifidobacterium bifidum is expected to have the biggest market share in 2024, driven by its widespread use in various applications and the growing consumer awareness of its benefits.

Applications of the Probiotics Strain Market

The food and beverages segment is the largest within the probiotics strain market. It includes products like yogurt, fermented milk, and other drinks that contain probiotics. In 2024, this segment is expected to dominate the market with a market revenue of $1451.24 million, reflecting the increasing consumer preference for health-enhancing foods and the growing trend of functional foods.

Probiotics are also used in animal feed to improve gut health and overall well-being in livestock. The market revenue for animal feed is projected to be $52.76 million in 2024, with a steady growth rate due to the increasing demand for natural and sustainable animal husbandry practices.

Dietary supplements containing probiotics are gaining popularity for their potential to support digestive health and immunity. In 2024, this application is expected to have a considerable market revenue of $305.61 million, with a growing rate as more consumers seek proactive health solutions.

This category includes other niche applications of probiotic strains, which may include industrial uses or specialized health products. The market revenue for “Others” is also expected to grow in 2024, albeit at a slower pace compared to the other segments.

The Food and Beverages application is anticipated to hold the biggest market share in 2024, driven by widespread consumer acceptance and the integration of probiotics into a variety of popular food products. On the other hand, the Dietary Supplements application is expected to exhibit the fastest-growing rate, fueled by the rising health consciousness and the quest for natural remedies to support gut health and immunity.

Market Revenue and Share by Segment

5. Regional Probiotics Strain Industry Analysis

Americas

The Americas have long been a significant player in the probiotics strain market. By 2024, the region is expected to reach a revenue of $564.52 million, driven by the United States’ robust health supplement industry and the growing demand for probiotic-enriched food and beverages. The region’s mature market and high health consciousness among consumers contribute to its leading position.

Asia Pacific

Asia Pacific is projected to be the fastest-growing region in the probiotics strain market by 2024 with a market revenue of $806.39 million. This growth is fueled by countries like China and India, where the burgeoning middle class and increasing health awareness are driving the demand for probiotic products. The region’s market share has been on the rise, surpassing that of the Americas in 2021, and this trend is expected to continue.

Europe

Europe, with its well-established market for health products, is expected to hold a considerable share of the probiotics strain market with a revenue of $432.50 million in 2024. The region’s revenue is bolstered by the presence of key players in the probiotics industry and a strong inclination towards natural health solutions among consumers.

The Asia Pacific region is projected to be the fastest-growing region, driven by economic growth and increasing health consciousness in countries like China and India.

Global Probiotics Strain (M USD) by Region in 2024

6. Analysis of the Top Five Companies in the Probiotics Strain Market

DuPont (Danisco)

Established in 1897 and headquartered in the USA, DuPont is a global leader in biotechnology and the manufacture of chemicals and pharmaceuticals. The company offers a range of probiotic products under the HOWARU® brand, targeting various health needs. With a strong market presence and a history of over a century in probiotics, DuPont is expected to generate substantial revenue in 2024, driven by its high-performance, stable, and functional probiotic strains.

Chr. Hansen

Founded in 1874 and based in Denmark, Chr. Hansen is renowned for its probiotic strains, with products like Lactobacillus rhamnosus, and LGG®. The company’s focus on scientific research and clinical trials has solidified its position in the market. Chr. Hansen’s commitment to advancing probiotic science is expected to result in significant revenue in 2024.

Lallemand

Established in 1915 and headquartered in Canada, Lallemand offers a unique range of probiotic strains under brands like Rosell® and LAFTI®. The company’s focus on women’s health and functional foods has been a key differentiator. Lallemand’s revenue in 2024 is projected to be substantial, driven by its innovative probiotic solutions.

Probi

Probi, founded in 1991 and headquartered in Sweden, is known for its comprehensive portfolio of probiotic products, such as Probi Digestis®. The company’s focus on clinical proof and strain efficacy positions it well in the market. Probi’s revenue in 2024 is expected to benefit from its strong brand presence and product diversity.

Biocodex

Founded in 1953 and based in France, Biocodex is known for its probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. The company’s expertise in gut microbiota has made it an international player in the probiotics realm. Biocodex’s revenue in 2024 is anticipated to grow due to its established product line and continuous research in microbiota health.

Major Players